Peginterferon alfa-2a Pegasys - Treatment - Hepatitis C Online
Por um escritor misterioso
Descrição
Peginterferon alfa-2a Pegasys - Treatment - Hepatitis C Online
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease - Clinical Gastroenterology and Hepatology
Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response - Gastroenterology
Future Therapies for Hepatitis C - Jean-Michel Pawlotsky, Robert G Gish, 2006
The way forward in HCV treatment — finding the right path
The way forward in HCV treatment — finding the right path
Peginterferon alfa-2a plus ribavirin for treating chronic hepatitis C virus infection: Analysis of Mexican patients included in a multicenter international clinical trial
PDF) Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial
Pathway to affordable, quality-assured sources of pegylated interferon alpha for treating hepatitis C - GaBI Journal
Viruses, Free Full-Text
Peginterferon alfa-2a Pegasys - Treatment - Hepatitis C Online
IJERPH, Free Full-Text
Peginterferon alfa-2a Pegasys - Treatment - Hepatitis C Online
de
por adulto (o preço varia de acordo com o tamanho do grupo)
/media/movies/covers/2022/05/FT_vIeWWYAEeKjS.jpg)
